Calcific Tendonitis Treatment-Barbotage vs. Barbotage with Cortisone Injection: A Randomized Controlled Double-Blind Study
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Calcific Tendonitis
-
Age: Between 18 years - 90 years
-
Gender: Male or Female
-
Other Inclusion Criteria:
- Subjects who are diagnosed with calcific tendonitis and ruled out other shoulder-related pathologies
- Subjects who failed 1st line therapy (physical therapy and cortisone injection)
- Subjects with intention to receive barbotage with cortisone as standard of care
- Subjects who have 3 or more months of shoulder pain
- Subjects with one or more calcifications =5 mm in size on either sonogram or radiograph, located on the supraspinatus tendon
- Positive Hawkin’s test or Neer’s sign for impingement
You may not be eligible for this study if the following are true:
-
- Legally incompetent or mentally impaired
- Subjects with osteoarthritis of the glenohumeral joint of the affected shoulder
- Subjects with previous surgery or barbotage to the affected shoulder
- History of prior allergic/hypersensitivity reactions related to the study medication
- Subjects with shoulder instability, glenohumeral arthritis, AC pathology, inflammatory arthropathy, fibromyalgia, frozen shoulder or cervical radiculopathy
- Subjects who had sub-acromial injection with a corticosteroid or treatment by ESWT during the last 3 months before inclusion
- Younger than 18 years of age or older than 90
- Any subjects considered a vulnerable subject
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.